World medicaments containing corticosteroid hormones market to reach 418K tons valued at $101B by 2035, driven by sustained global demand.

IndexBox has just published a new report: World - Medicaments Containing Corticosteroid Hormones - Market Analysis, Forecast, Size, Trends And Insights.

The global market for medicaments containing corticosteroid hormones is projected to experience sustained growth over the next decade, fueled by increasing worldwide demand. While market performance is forecast to decelerate, it will continue an upward trend. In terms of volume, the market is anticipated to expand at a compound annual growth rate (CAGR) of +1.7% from 2024 through 2035, culminating in a total market volume of 418,000 tons by the end of 2035. In value terms, growth is projected to be stronger, with an anticipated CAGR of +3.1% for the same period. This growth in nominal prices is expected to bring the total market value to $101 billion by 2035.

Market Forecast

Driven by increasing demand for medicaments containing corticosteroid hormones worldwide, the market is expected to continue an upward consumption trend over the next decade. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +1.7% for the period from 2024 to 2035, which is projected to bring the market volume to 418K tons by the end of 2035.

In value terms, the market is forecast to increase with an anticipated CAGR of +3.1% for the period from 2024 to 2035, which is projected to bring the market value to $101B (in nominal wholesale prices) by the end of 2035.

Consumption

World's Consumption of Medicaments Containing Corticosteroid Hormones

In 2024, consumption of medicaments containing corticosteroid hormones increased by 9.5% to 347K tons, rising for the fourth year in a row after two years of decline. The total consumption volume increased at an average annual rate of +3.5% from 2012 to 2024; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. Global consumption peaked in 2024 and is expected to retain growth in the near future.

The global medicaments containing corticosteroid hormones market value rose notably to $71.9B in 2024, picking up by 10% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, the total consumption indicated a measured expansion from 2012 to 2024: its value increased at an average annual rate of +4.8% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, consumption increased by +77.9% against 2013 indices. Global consumption peaked in 2024 and is expected to retain growth in years to come.

Consumption By Country

The countries with the highest volumes of consumption in 2024 were Denmark (79K tons), China (49K tons) and Turkey (28K tons), with a combined 45% share of global consumption.

From 2012 to 2024, the most notable rate of growth in terms of consumption, amongst the leading consuming countries, was attained by Denmark (with a CAGR of +60.1%), while consumption for the other global leaders experienced more modest paces of growth.

In value terms, Denmark ($27.8B) led the market, alone. The second position in the ranking was held by the United States ($10.2B). It was followed by Japan.

In Denmark, the medicaments containing corticosteroid hormones market expanded at an average annual rate of +60.5% over the period from 2012-2024. In the other countries, the average annual rates were as follows: the United States (-1.1% per year) and Japan (-1.2% per year).

In 2024, the highest levels of medicaments containing corticosteroid hormones per capita consumption was registered in Denmark (13 kg per person), followed by Turkey (0.3 kg per person), the UK (0.1 kg per person) and Japan (0.1 kg per person), while the world average per capita consumption of medicaments containing corticosteroid hormones was estimated at less than 0.1 kg per person.

In Denmark, medicaments containing corticosteroid hormones per capita consumption increased at an average annual rate of +59.2% over the period from 2012-2024. The remaining consuming countries recorded the following average annual rates of per capita consumption growth: Turkey (+12.5% per year) and the UK (+5.7% per year).

Production

World's Production of Medicaments Containing Corticosteroid Hormones

In 2024, production of medicaments containing corticosteroid hormones increased by 13% to 337K tons, rising for the fourth year in a row after two years of decline. Overall, the total production indicated prominent growth from 2012 to 2024: its volume increased at an average annual rate of +5.2% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, production increased by +32.7% against 2020 indices. The pace of growth appeared the most rapid in 2017 with an increase of 22% against the previous year. Global production peaked in 2024 and is likely to continue growth in the near future.

In value terms, medicaments containing corticosteroid hormones production skyrocketed to $67.6B in 2024 estimated in export price. The total output value increased at an average annual rate of +4.3% over the period from 2012 to 2024; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. As a result, production attained the peak level and is likely to continue growth in the immediate term.

Production By Country

The countries with the highest volumes of production in 2024 were Denmark (62K tons), China (46K tons) and India (33K tons), with a combined 42% share of global production.

From 2012 to 2024, the most notable rate of growth in terms of production, amongst the key producing countries, was attained by Denmark (with a CAGR of +94.0%), while production for the other global leaders experienced more modest paces of growth.

Imports

World's Imports of Medicaments Containing Corticosteroid Hormones

In 2024, global medicaments containing corticosteroid hormones imports reduced modestly to 180K tons, waning by -4.6% compared with the previous year. Over the period under review, total imports indicated a perceptible expansion from 2012 to 2024: its volume increased at an average annual rate of +3.1% over the last twelve years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, imports increased by +57.9% against 2017 indices. The pace of growth appeared the most rapid in 2018 when imports increased by 21% against the previous year. Global imports peaked at 188K tons in 2023, and then fell in the following year.

In value terms, medicaments containing corticosteroid hormones imports dropped modestly to $50.8B in 2024. Overall, total imports indicated a resilient increase from 2012 to 2024: its value increased at an average annual rate of +5.1% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, imports increased by +82.3% against 2012 indices. The growth pace was the most rapid in 2018 with an increase of 13%. Over the period under review, global imports attained the peak figure at $51.1B in 2023, and then fell in the following year.

Imports By Country

The United States (22K tons) and Denmark (19K tons) represented roughly 23% of total imports in 2024. The UK (12K tons) held a 6.9% share (based on physical terms) of total imports, which put it in second place, followed by China (6.4%). France (6.9K tons), Germany (6.9K tons), Afghanistan (5.6K tons), Japan (5.2K tons), Spain (4.7K tons) and Belgium (4.7K tons) followed a long way behind the leaders.

From 2012 to 2024, the biggest increases were recorded for Afghanistan (with a CAGR of +47.7%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the United States ($8.7B), China ($4.9B) and the UK ($3.8B) appeared to be the countries with the highest levels of imports in 2024, together comprising 34% of global imports. France, Germany, Japan, Spain, Belgium, Denmark and Afghanistan lagged somewhat behind, together accounting for a further 25%.

Among the main importing countries, Afghanistan, with a CAGR of +39.3%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices By Country

In 2024, the average medicaments containing corticosteroid hormones import price amounted to $282,787 per ton, growing by 4.1% against the previous year. Over the period from 2012 to 2024, it increased at an average annual rate of +2.0%. The pace of growth appeared the most rapid in 2013 when the average import price increased by 16% against the previous year. Global import price peaked at $305,993 per ton in 2022; however, from 2023 to 2024, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Japan ($456,439 per ton), while Afghanistan ($7,192 per ton) was amongst the lowest.

From 2012 to 2024, the most notable rate of growth in terms of prices was attained by Spain (+17.7%), while the other global leaders experienced more modest paces of growth.

Exports

World's Exports of Medicaments Containing Corticosteroid Hormones

Global medicaments containing corticosteroid hormones exports totaled 169K tons in 2024, remaining constant against 2023. Over the period under review, total exports indicated prominent growth from 2012 to 2024: its volume increased at an average annual rate of +6.6% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, exports increased by +114.6% against 2012 indices. The most prominent rate of growth was recorded in 2023 with an increase of 19%. The global exports peaked in 2024 and are expected to retain growth in the near future.

In value terms, medicaments containing corticosteroid hormones exports expanded rapidly to $48B in 2024. Overall, total exports indicated a prominent increase from 2012 to 2024: its value increased at an average annual rate of +7.0% over the last twelve-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2024 figures, exports increased by +74.7% against 2014 indices. The most prominent rate of growth was recorded in 2013 with an increase of 19%. Over the period under review, the global exports attained the peak figure in 2024 and are expected to retain growth in years to come.

Exports By Country

In 2024, France (19K tons), Italy (19K tons), Pakistan (15K tons), India (14K tons), Belgium (12K tons), Germany (11K tons), China (8.2K tons), the United States (7.5K tons) and Ireland (7.4K tons) represented the major exporter of medicaments containing corticosteroid hormones in the world, mixing up 66% of total export. The Netherlands (7.4K tons) held a minor share of total exports.

From 2012 to 2024, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Pakistan (with a CAGR of +22.3%), while the other global leaders experienced more modest paces of growth.

In value terms, Italy ($9.9B), France ($5.4B) and Germany ($4.8B) constituted the countries with the highest levels of exports in 2024, with a combined 42% share of global exports. The United States, the Netherlands, Belgium, Ireland, China, India and Pakistan lagged somewhat behind, together comprising a further 28%.

In terms of the main exporting countries, China, with a CAGR of +29.3%, recorded the highest growth rate of the value of exports, over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices By Country

In 2024, the average medicaments containing corticosteroid hormones export price amounted to $283,700 per ton, increasing by 9.8% against the previous year. Overall, the export price recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2020 an increase of 20% against the previous year. The global export price peaked at $308,886 per ton in 2014; however, from 2015 to 2024, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Italy ($529,963 per ton), while Pakistan ($9,803 per ton) was amongst the lowest.

From 2012 to 2024, the most notable rate of growth in terms of prices was attained by China (+19.0%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform